Cannara Biotech Inc.
LOVE.TO
TSX
| 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | |
|---|---|---|---|---|---|
| Revenue | 19.91M | 21.55M | 20.54M | 19.39M | 18.49M |
| Total Other Revenue | -- | 23.90K | 248.10K | -- | -- |
| Total Revenue | 19.91M | 21.57M | 20.79M | 19.39M | 18.49M |
| Cost of Revenue | 11.39M | 13.54M | 11.76M | 10.28M | 10.22M |
| Gross Profit | 8.52M | 8.03M | 9.03M | 9.12M | 8.27M |
| SG&A Expenses | 5.57M | 5.70M | 4.62M | 4.07M | 3.93M |
| Depreciation & Amortization | 185.50K | 191.10K | 567.00K | 158.70K | 196.80K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 17.44M | 19.63M | 17.08M | 14.63M | 14.47M |
| Operating Income | 2.47M | 1.94M | 3.71M | 4.76M | 4.02M |
| Income Before Tax | 2.07M | 1.46M | 3.31M | 4.12M | 3.30M |
| Income Tax Expenses | 848.60K | 717.30K | 894.80K | 1.17M | 988.60K |
| Earnings from Continuing Operations | 1.22M | 744.60K | 2.42M | 2.95M | 2.32M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.22M | 744.60K | 2.42M | 2.95M | 2.32M |
| EBIT | 2.47M | 1.94M | 3.71M | 4.76M | 4.02M |
| EBITDA | 3.38M | 3.02M | 5.29M | 5.61M | 5.11M |
| EPS Basic | 0.01 | 0.01 | 0.03 | 0.03 | 0.03 |
| Normalized Basic EPS | 0.01 | 0.01 | 0.02 | 0.03 | 0.02 |
| EPS Diluted | 0.01 | 0.01 | 0.02 | 0.03 | 0.03 |
| Normalized Diluted EPS | 0.01 | 0.01 | 0.02 | 0.03 | 0.02 |
| Average Basic Shares Outstanding | 96.36M | 93.72M | 91.44M | 91.43M | 90.56M |
| Average Diluted Shares Outstanding | 98.42M | 96.18M | 93.38M | 92.61M | 92.25M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |